UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Inhaled insulin--does it become reality?

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2008-12, Vol.59 Suppl 6, p.81

2008

Volltextzugriff (PDF)

Lung deposition of inhaled alpha-1-proteinase inhibitor (alpha 1-PI) - problems and experience of alpha1-PI inhalation therapy in patients with hereditary alpha1-PI deficiency and cystic fibrosis

European journal of medical research, 2010-11, Vol.15 Suppl 2 (S2), p.164-174, Article 164

Siekmeier, R

2010

Volltextzugriff (PDF)

Systemic treatment by inhalation of macromolecules--principles, problems, and examples

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2008-12, Vol.59 Suppl 6, p.53

2008

Volltextzugriff (PDF)

Novel devices for individualized controlled inhalation can optimize aerosol therapy in efficacy, patient care and power of clinical trials

European journal of medical research, 2009-12, Vol.14 Suppl 4 (Suppl 4), p.71-77

2009

Volltextzugriff (PDF)

Novel approaches to enhance pulmonary delivery of proteins and peptides

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2007-11, Vol.58 Suppl 5 (Pt 2), p.615-625

2007

Volltextzugriff (PDF)

Market surveillance of in vitro diagnostics by the BfArM until end 2010: how safe are products for tumor diagnostics?

Advances in experimental medicine and biology, 2013-01, Vol.755, p.385

2013

Volltextzugriff (PDF)

Market surveillance of in vitro diagnostics by the BfArM until end 2010: safety of IVD for therapeutic drug monitoring

Advances in experimental medicine and biology, 2013-01, Vol.755, p.375

2013

Volltextzugriff (PDF)

Treatment of systemic diseases by inhalation of biomolecule aerosols

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2009-11, Vol.60 Suppl 5, p.15

2009

Volltextzugriff (PDF)

C-reactive protein and lipoprotein-associated phospholipase A2 in smokers and nonsmokers of the Ludwigshafen Risk and Cardiovascular Health study

Advances in experimental medicine and biology, 2015, Vol.832, p.15

2015

Volltextzugriff (PDF)

Die Sicherheit von Hochrisiko-in-vitro-Diagnostika: Internationale und nationale Maßnahmen

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2009-06, Vol.52 (6), p.610-618

2009

Volltextzugriff (PDF)

Influence of smoking and body weight on adipokines in middle aged women

European journal of medical research, 2009-12, Vol.14 Suppl 4 (Suppl 4), p.21-26

2009

Volltextzugriff (PDF)

Impact of traffic-related air pollution on health

Advances in experimental medicine and biology, 2015, Vol.834, p.21

2015

Volltextzugriff (PDF)

Inhalation of macrolides: a novel approach to treatment of pulmonary infections

Advances in experimental medicine and biology, 2015, Vol.839, p.13

2015

Volltextzugriff (PDF)

GINA 2017 – Neues und Wichtiges zum Asthma bronchiale

Atemwegs- und Lungenkrankheiten, 2018-08, Vol.44 (8), p.396-400

Siekmeier, R.

2018

Volltextzugriff (PDF)

Effect of HMG CoA reductase inhibitors on low-density lipoprotein cholesterol and C-reactive protein: systematic review and meta-analysis

International journal of clinical pharmacology and therapeutics, 2008-10, Vol.46 (10), p.497-510

2008

Volltextzugriff (PDF)

Selective Isolation of Pseudallescheria and Scedosporium Species from Respiratory Tract Specimens of Cystic Fibrosis Patients

Respiration, 2009-01, Vol.77 (3), p.320-324

2009

Volltextzugriff (PDF)

Können Antioxidanzien Atherosklerose verhindern?

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2006-10, Vol.49 (10), p.1034-1049

2006

Volltextzugriff (PDF)

Wie sicher sind Testsysteme zur Diagnostik von Infektionskrankheiten?: Erfahrungen des Bundesinstitutes für Arzneimittel und Medizinprodukte mit den dort bis Ende 2005 eingegangenen Meldungen

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2008-02, Vol.51 (2), p.221-234

2008

Volltextzugriff (PDF)

Isolation of fungi, especially Exophiala dermatitidis, in patients suffering from cystic fibrosis: A prospective study

Respiration, 2004-07, Vol.71 (4), p.360-366

2004

Volltextzugriff (PDF)

Detection of hyphomycetes in the upper respiratory tract of patients with cystic fibrosis

Mycoses, 2011-11, Vol.54 (6), p.514-522

2011

Volltextzugriff (PDF)

Alterations in the coagulation system of active smokers from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study

Advances in experimental medicine and biology, 2015, Vol.832, p.9

2015

Volltextzugriff (PDF)

Field safety notices released by manufacturers in cases of failure of products for infection testing: analysis of cases reported to the BfArM between 2005 and 2007

European journal of medical research, 2010-11, Vol.15 Suppl 2 (S2), p.175-183, Article 175

2010

Volltextzugriff (PDF)

Safety of laboratory analyzers for infection testing - results of the market surveillance by the BfArM until End 2007

European journal of medical research, 2009-12, Vol.14 Suppl 4 (Suppl 4), p.216-226

2009

Volltextzugriff (PDF)

Safety of reagents for infection testing: results of the market surveillance by the Federal Institute for Drugs and Medicinal Devices until end 2006

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2008-12, Vol.59 Suppl 6, p.629

2008

Volltextzugriff (PDF)

Associations of carotenoids, vitamin A and mortality: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study

Atherosclerosis, 2023-08, Vol.379, p.S164-S165

2023

Volltextzugriff (PDF)

1 – 25 von 189

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(171)
Mit Volltextzugriff
(132)

Publikationsform

Sprache

Englisch
(132)
Deutsch
(58)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Inhaled insulin--does it become reality?

Lung deposition of inhaled alpha-1-proteinase inhibitor (alpha 1-PI) - problems and experience of alpha1-PI inhalation therapy in patients with hereditary alpha1-PI deficiency and cystic fibrosis

Systemic treatment by inhalation of macromolecules--principles, problems, and examples

Novel devices for individualized controlled inhalation can optimize aerosol therapy in efficacy, patient care and power of clinical trials

Novel approaches to enhance pulmonary delivery of proteins and peptides

Market surveillance of in vitro diagnostics by the BfArM until end 2010: how safe are products for tumor diagnostics?

Market surveillance of in vitro diagnostics by the BfArM until end 2010: safety of IVD for therapeutic drug monitoring

Treatment of systemic diseases by inhalation of biomolecule aerosols

C-reactive protein and lipoprotein-associated phospholipase A2 in smokers and nonsmokers of the Ludwigshafen Risk and Cardiovascular Health study

Die Sicherheit von Hochrisiko-in-vitro-Diagnostika: Internationale und nationale Maßnahmen

Influence of smoking and body weight on adipokines in middle aged women

Impact of traffic-related air pollution on health

Inhalation of macrolides: a novel approach to treatment of pulmonary infections

GINA 2017 – Neues und Wichtiges zum Asthma bronchiale

Effect of HMG CoA reductase inhibitors on low-density lipoprotein cholesterol and C-reactive protein: systematic review and meta-analysis

Selective Isolation of Pseudallescheria and Scedosporium Species from Respiratory Tract Specimens of Cystic Fibrosis Patients

Können Antioxidanzien Atherosklerose verhindern?

Wie sicher sind Testsysteme zur Diagnostik von Infektionskrankheiten?: Erfahrungen des Bundesinstitutes für Arzneimittel und Medizinprodukte mit den dort bis Ende 2005 eingegangenen Meldungen

Isolation of fungi, especially Exophiala dermatitidis, in patients suffering from cystic fibrosis: A prospective study

Detection of hyphomycetes in the upper respiratory tract of patients with cystic fibrosis

Alterations in the coagulation system of active smokers from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study

Field safety notices released by manufacturers in cases of failure of products for infection testing: analysis of cases reported to the BfArM between 2005 and 2007

Safety of laboratory analyzers for infection testing - results of the market surveillance by the BfArM until End 2007

Safety of reagents for infection testing: results of the market surveillance by the Federal Institute for Drugs and Medicinal Devices until end 2006

Associations of carotenoids, vitamin A and mortality: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study

Suchergebnisse filtern